Economy

Weight-Loss Pills in 2026: What the Wegovy Pill and Foundayo Cost With and Without Insurance

By EcoPress Newsroom · November 14, 2026 · 8 min read

The Wegovy pill has a list price near $1,349 a month but self-pay offers start at $149, and Lilly's orforglipron pill (Foundayo) is also reported from about $149 a month. Prices depend on dose and channel.

The first weight-loss pills in the GLP-1 class are now on sale, and cost is the main question. Most figures below come from health and pharmacy guides, many of them commercial, so confirm prices with Novo Nordisk, Eli Lilly or your pharmacy before you buy.

Prescription bottles
Prescription bottles. Illustrative image. Photo: Bart from New York, USA, CC BY 2.0, via Wikimedia Commons

Reported prices per month

ProductReported costNotes
Wegovy pill (oral semaglutide), list priceAbout $1,349Before insurance, coupons or discounts
Wegovy pill, NovoCare self-pay$149 (1.5 mg), $199 (4 mg), $299 (9 mg and 25 mg)Self-pay price; insurance may be lower, with some reports as low as $25 depending on the plan
Foundayo (orforglipron, Lilly)Self-pay from about $149; one guide gives $149 to $349Approved April 1, 2026 for weight management; no confirmed list price in the sources
Wegovy injection, NovoCare self-pay$349 for standard doses; $399 for 7.2 mgA $199 introductory offer was also reported
Zepbound, LillyDirect$299 to $449Without insurance

Before you decide

  • These are prescription drugs. A clinician decides whether one is appropriate and at what dose.
  • The FDA has just required an eye-risk warning on every drug in the class; see our report on that warning.
  • One source expects cash prices to start near $350 a month and fall toward about $245 over two years, a target, not a promise.
Not medical advice: Talk to a doctor about side effects, eligibility and monitoring. Check manufacturer sites for current prices.

Also on EcoPress: FDA Orders an Eye-Risk Warning on Every GLP-1 Drug: What Patients Should Know · Coffee, Flu Shots and Weight-Loss Surgery: How to Read This Week's Health Headlines

Sources and further reading: Drugs.com on Wegovy costs; Noom guide. Figures are as reported on the date of publication and may change.

Disclaimer: The information provided by EcoPress is for general informational purposes only and does not constitute investment advice, financial advice, trading advice, or any other sort of advice. EcoPress does not recommend that any security, transaction, or investment strategy is suitable for any specific person. Readers should conduct their own research and consult with independent financial advisors before making any financial decisions. EcoPress is not responsible for any losses incurred as a result of using information published on this site.

About the Author

Leave a Comment

No comments yet.

Sponsored